Connecticut · Ranked 53 of 1033 by CEO pay.
Yale New Haven Hospital
Christopher O'Connor, CEO/Trustee (Vested Deferred). Fiscal year ending 2025-09.
Form 990 Part VII, columns D+E+F
Schedule H Part I line 7a
Most of the reported compensation ($3,964,082 of $4,968,969) came from a related organization (Part VII column E) and was reported on this filing.
§1The filing
- Total revenue
- $4,883,266,662
- Total expenses
- $4,720,875,475
- Net assets
- $3,388,108,016
- Employees
- 18,097
- Hospitals covered
- 1 facilities across 1 filing
- Charity care, net
- $124,786,122
- Bad debt
- $79,730,000
- Medicare surplus (shortfall), as filed
- ($102,814,220)
- CEO pay from the organization (Part VII col. D)
- $0
- From related organizations (col. E)
- $3,964,082
- Other compensation, including deferred pay and nontaxable benefits (col. F)
- $1,004,887
- CEO total compensation (D+E+F)
- $4,968,969 to Christopher O'Connor
Medicare surplus (shortfall) is Schedule H Part III line 7: Medicare revenue minus the cost of Medicare care. A figure in parentheses is a shortfall. Like bad debt, it is not community benefit on the IRS form.
Source: Form 990, Yale New Haven Hospital, EIN 06-0646652, fiscal year ending 2025-09, as published by the IRS. CEO identification: ceo title.
§2Community benefit versus charity care
The rest of line 7k is Medicaid shortfall, medical education, research, subsidized services and contributions. Bad debt ($79.7M) and Medicare shortfall are reported separately by the IRS and are not community benefit on the form.
Every number on this page was copied from the filing linked above. If a figure is wrong, send the filing that contradicts it and the correction runs at the top of this page.
§Share
